Let's talk about Santa’s Naughty and Nice list for this Christmas.And no, I'm not talking about your Uncle Frank who brings deviled eggs to every family dinner, or that one cousin who still owes you 50 bucks.I'm talking about stocks. The stocks handing out profits like candy canes – and the ones you want to avoid like a regifted fruitcake.The stocks that are showing every sign of being massive winners next year, and the ones you need to sell right away.The Naughty ListThese are the stocks where options pric ...

During D’Souza’s tenure, Cognizant carved out a strong franchise in healthcare, with the former CEO playing a pivotal role in the $2.7 billion all-cash acquisition of TriZetto in 2014 — a landmark deal that anchored Cognizant’s healthtech ambitions. TriZetto’s platform connects with 11,000 payers and processes more than 4 billion transactions a year.Early in its growth journey, Cognizant rapidly expanded its healthcare presence, counting nine of the top 10 payers — including United, Anthem, Cigna, and Aetna ...

Core Viewpoint - The market anticipates that Phreesia (PHR) will report a year-over-year increase in earnings driven by higher revenues when it releases its quarterly results for the period ending October 2025 [1] Earnings Expectations - The earnings report is scheduled for December 8, and if the results exceed expectations, the stock may rise; conversely, a miss could lead to a decline [2] - The consensus estimate for Phreesia's quarterly earnings is projected at $0.00 per share, reflecting a year-over-year increase of +100%, with revenues expected to reach $120.13 million, a 12.5% increase from the previous year [3] Estimate Revisions - The consensus EPS estimate has been revised 50% higher in the last 30 days, indicating a positive reassessment by analysts [4] - The Most Accurate Estimate for Phreesia is significantly higher than the Zacks Consensus Estimate, resulting in an Earnings ESP of +1,100.00%, suggesting a bullish outlook from analysts [12] Earnings Surprise Prediction - The Zacks Earnings ESP model indicates that a positive Earnings ESP reading is a strong predictor of an earnings beat, especially when combined with a Zacks Rank of 1 (Strong Buy), 2 (Buy), or 3 (Hold) [10] - Phreesia currently holds a Zacks Rank of 2, reinforcing the likelihood of beating the consensus EPS estimate [12] Historical Performance - In the last reported quarter, Phreesia was expected to incur a loss of $0.07 per share but instead reported earnings of $0.01, resulting in a surprise of +114.29% [13] - Over the past four quarters, Phreesia has consistently beaten consensus EPS estimates [14]

Financial Data and Key Metrics Changes - The company achieved record quarterly revenues of $76.5 million, up 4.6% from the same quarter last year [12] - Operating income increased by 16.5% to $7.6 million, while net income rose by 6.3% to $6.1 million [6][12] - Adjusted EBITDA reached a new record high of $19.1 million, up 7.9% year-over-year [12][16] - Gross margin was 65.3%, slightly down from 66.5% in the prior year due to increased cloud hosting and software licensing costs [15] Business Line Data and Key Metrics Changes - Subscription product revenues increased by $4 million or 5.7%, while professional service revenues decreased by $600,000 or 18.6% [14] - CredentialStream grew by 23%, Shift Wizard by 29%, and Competency Suite by 18% [14][38] - Revenues from legacy applications declined by $1.7 million compared to last year, but the core business grew by 8% when excluding legacy impacts [14] Market Data and Key Metrics Changes - The company has over 25 active accounts in the payer market following the acquisition of Versus twelve, which enhances its capabilities in provider data management [7] - The total addressable market for the company's SaaS solutions includes 12.6 million healthcare professionals and nursing students in the U.S. [11] Company Strategy and Development Direction - The company is focused on expanding its career networks, which provide value directly to healthcare professionals, while also enhancing its enterprise application suites [26][28] - The acquisition of Versus twelve is expected to strengthen the company's position in the payer market and improve provider data management capabilities [7][21] - The company maintains a disciplined approach to capital allocation, prioritizing organic investments, acquisitions, dividends, and share repurchases [20] Management's Comments on Operating Environment and Future Outlook - Management updated financial guidance for the full year 2025, maintaining midpoints while narrowing ranges for key metrics [6][22] - The company anticipates approximately $900,000 in revenue contribution from the Versus twelve acquisition in Q4, offset by a $3 million expected decline in legacy products [22][94] - Management expressed optimism about the growth trajectory of its core solutions and the potential for higher margins due to a shift towards proprietary content [50][52] Other Important Information - The company ended the quarter with a cash balance of $92.6 million and no interest-bearing debt [11][19] - A quarterly cash dividend of $0.31 per share was declared, to be paid on November 28 [22] Q&A Session Summary Question: Can you provide more details on the Versus twelve acquisition and its market? - Management indicated that the acquisition enhances capabilities in provider data management and brings valuable expertise to the team, which will help meet market needs [43][46] Question: What are the prospects for adjusted EBITDA margins? - Management noted that the shift towards owning more content and higher-margin products could lead to upward pressure on margins over time [47][50] Question: Can you provide insights on the revenue mix from Versus twelve? - Management estimated a contribution of approximately $900,000 in Q4, with a mix of subscription and consulting revenue, but did not provide specific breakdowns [56] Question: What monetization strategies are being pursued for the career networks? - Management outlined several monetization strategies, including education offerings and job capabilities, with a focus on building value-added services for users [59][62] Question: Is Shift Wizard ready for larger organizations? - Management confirmed that while it is not fully ready for the largest organizations, there is a good pipeline of opportunities in the upper middle market [83] Question: What bundling strategies are being implemented for small hospitals? - Management discussed the introduction of a critical access bundle aimed at providing a comprehensive solution at a better price, addressing economic pressures faced by small hospitals [88]

Core Viewpoint - Waystar Holding Corp. will report its financial results for Q3 2025 on October 29, 2025, after market close, followed by a conference call to discuss the results [1]. Company Overview - Waystar provides healthcare payment software designed to simplify payment processes, allowing providers to focus on patient care and financial performance [3]. - The company serves approximately 30,000 clients, which includes over 1 million distinct providers, and 17 out of the 20 institutions listed in U.S. News Best Hospitals [3]. - Waystar's platform processes over 6 billion healthcare payment transactions annually, managing over $1.8 trillion in gross claims and covering about 50% of U.S. patients [3].

Core Insights - VitalHub Corp. has announced its first deployment of Novari Health's technology in the UK, expanding its geographic footprint beyond Canada and Australia [1][2] - The South West Provider Collaborative, which serves over 5.5 million people, will utilize Novari's electronic referral and bed management solution across multiple mental health service lines [2][5] Company Overview - Novari Health, a subsidiary of VitalHub, specializes in cloud-based referral management and wait list management software solutions aimed at improving access to care and operational efficiency [8][10] - VitalHub is a leading software company focused on empowering health and human services providers globally, with a comprehensive product suite that includes electronic health records and operational intelligence [9][10] Technology Features - The Novari technology is designed specifically for mental health, providing real-time bed visibility, structured workflows, and wait list management to enhance patient care [3][4] - Optional AI-enhanced analytics are available to provide real-time data on patient waiting times, improving resource utilization and operational efficiency [4] Impact on Healthcare - The deployment of Novari's technology aims to optimize bed usage and improve patient care by ensuring timely access to mental health services [5][6] - The South West Provider Collaborative's innovative approach has transformed the mental healthcare landscape in the region, prioritizing patient wellbeing and community connection [7]

Company Overview - Judi Health, founded by AJ Loiacono, aims to address inefficiencies in the healthcare industry, which incurs $1 trillion in administrative spending annually [1] - The company, previously known as Capital Rx, has developed a modular cloud-based software that enhances pricing transparency in pharmacy benefit management [4] Financial Performance - Judi Health has achieved a revenue expectation of $3.7 billion for the current year, reflecting a growth of over 75% from last year's revenue of $2.1 billion [5] - The company recently announced a $400 million investment, including a $252 million Series F funding round, which has doubled its valuation to $3.25 billion [2] Operational Efficiency - Judi Health has successfully reduced costs by 11% for 1,800 plan members and decreased claims processing times from over six months to 18 days [1] - The company's pricing model involves charging flat administrative fees based on a per-member monthly basis or per-claim structure, utilizing the national average drug acquisition cost database for drug pricing [4] Market Context - U.S. pharmacy spending is projected to increase by $50 billion in 2024, reaching $487 billion at net manufacturer prices, driven by growth in various therapeutic areas including oncology and diabetes [5]

Core Insights - Hinge Health Inc. is identified as a strong investment opportunity with significant business momentum and product innovation [1][3] - The company reported a 55% year-over-year revenue increase in Q2 2025, reaching $139 million [1] - Stifel analyst raised the price target for Hinge Health to $66, reflecting confidence in the company's growth prospects [1] Business Expansion - Hinge Health has expanded its network to over 50 partners, including the five largest national health plans and the top three pharmacy benefit managers (PBMs) [2] - The company has launched innovative products such as AI-powered motion tracking technology and Hinge Select, a high-performance provider network [2] Client Engagement and Pricing Model - The company reported strong client retention rates and a record high member Net Promoter Score (NPS) in the first half of the year, attributed to a positive product experience [3] - Approximately 40% of clients transitioned to a new pay-as-you-go pricing model by the end of Q2, which includes an upfront platform fee, enhancing accountability for product engagement [3]

Core Insights - Wayar is hosting its True North conference in Nashville to showcase new AI solutions in healthcare software, addressing the challenges of higher utilization and costs faced by healthcare providers [1][3] - The healthcare sector has seen a significant increase in patient visits, averaging 1-2% annually over the last 40 years, with a notable 4% increase in the last two years, necessitating more efficient resource management by hospitals [5] - Wayar's AI technology automates low complexity, high volume tasks, allowing healthcare providers to improve efficiency and accuracy in patient interactions and billing processes [5][7] Company Overview - Wayar processes over six billion insurance transactions annually, amounting to more than $1.8 trillion in gross claim charges, enabling better financial transparency for patients [9] - The company aims to transition from AI hype to a reality focused on return on investment (ROI) for healthcare providers, enhancing patient-provider interactions [8][12] - Wayar's software platform allows providers to help patients understand their financial responsibilities before receiving care, promoting a more consumer-friendly experience [10][11] Industry Context - The healthcare industry is experiencing a shift towards utilizing AI to manage increased patient interactions, including telehealth and virtual consultations, which are becoming integral to patient care [6] - There is a growing emphasis on price transparency in healthcare, with mandates for providers to publish prices for certain services, and Wayar is positioned to facilitate this process [11]

Healthcare Industry Trends - Patient visits have increased by an average of 1-2% annually over the past 40 years, with a higher increase of about 4% in the last two years [5] - Telehealth interactions and other virtual interactions are included in the utilization metrics, not just physical patient visits [6] - UnitedHealth is experiencing challenges due to higher utilization and costs [1] Waystar's AI Solutions - Waystar utilizes AI to address higher utilization with more efficiency, helping clients get paid accurately, efficiently, and fully [3] - Waystar's AI automates low complexity, high volume tasks, returning more time to providers and improving accuracy and efficiency [5][6] - Waystar's software helps providers understand a patient's financial situation and automatically creates accurate claims [7] - Waystar's AI-powered platform processes over 6 billion insurance transactions annually, constituting more than $18 trillion of insurance gross claim charges [9] - Waystar's platform enables providers to interact with patients and help them understand their financial responsibility before receiving care [10] Transparency and ROI - Waystar helps patients understand their financial responsibility, offering more transparency than historically available [9][10] - Waystar is creating a real ROI for the providers they work with [7][12] - Waystar advocates for both providers and patients, bringing simplicity and common understanding to pricing [11]